We are live on ! Find out more
EVMN

Evommune Inc
EVMN

59 hedge funds and large institutions have $466M invested in Evommune Inc in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

86.29% more ownership

Funds ownership: 0% → 86.29% (+86%)

Holders
59
Holders Change
+59
Holders Change %
–
% of All Funds
0.72%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.09%
New
59
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EFM
EQT Fund Management
Luxembourg
+$92.6M
2
RCM
RA Capital Management
Massachusetts
+$65M
3
PBPIA
Pivotal bioVenture Partners Investment Advisor
California
+$36.2M
4
NFGH
Nan Fung Group Holdings
Hong Kong
+$27.1M
5
JP Morgan Chase
JP Morgan Chase
New York
+$24.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
26
Sphera Funds Management
Israel
$2.84M +$3.12M +166,147 New
SI
27
Sofinnova Investments
California
$2.62M +$2.88M +153,320 New
BlackRock
28
BlackRock
New York
$2.44M +$2.68M +142,440 New
IHAM
29
Integral Health Asset Management
New York
$2.14M +$2.35M +125,000 New
MB
30
MPM BioImpact
Massachusetts
$1.93M +$2.12M +113,022 New
Geode Capital Management
31
Geode Capital Management
Massachusetts
$1.88M +$2.06M +109,781 New
Ameriprise
32
Ameriprise
Minnesota
$1.79M +$1.96M +104,555 New
SGM
33
Seven Grand Managers
New York
$1.28M +$1.41M +75,000 New
SC
34
Stempoint Capital
New York
$1.17M +$1.28M +68,196 New
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$1.11M +$1.22M +65,000 New
Charles Schwab
36
Charles Schwab
California
$1.07M +$1.18M +62,704 New
Goldman Sachs
37
Goldman Sachs
New York
$1.06M +$1.16M +61,675 New
CFM
38
Capricorn Fund Managers
United Kingdom
$1.03M +$1.13M +60,000 New
Citadel Advisors
39
Citadel Advisors
Florida
$866K +$950K +50,560 New
BGM
40
Burkehill Global Management
New York
$856K +$939K +50,000 New
TD Asset Management
41
TD Asset Management
Ontario, Canada
$764K +$838K +44,634 New
Point72 Asset Management
42
Point72 Asset Management
Connecticut
$589K +$646K +34,384 New
Tudor Investment Corp
43
Tudor Investment Corp
Connecticut
$547K +$600K +31,953 New
State Street
44
State Street
Massachusetts
$539K +$592K +31,500 New
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
$412K +$452K +24,057 New
Northern Trust
46
Northern Trust
Illinois
$388K +$425K +22,636 New
Two Sigma Investments
47
Two Sigma Investments
New York
$365K +$401K +21,324 New
OAM
48
Oxford Asset Management
United Kingdom
$335K +$368K +19,565 New
XT
49
XTX Topco
Cayman Islands
$321K +$353K +18,778 New
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$179K +$192K +10,225 New
1
2
3

EVMN Hedge Fund Activity: Q4 2025 in Review

59 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in Evommune Inc (EVMN) for Q4 2025, worth a combined $466M.

Buyers outnumbered sellers: 59 funds opened new EVMN positions and 0 closed out — a net gain of 59 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was EQT Fund Management, opening a new position worth an estimated $92.6M.

  • 59 institutional investors held Evommune Inc (EVMN) as of Q4 2025, up from 0 in Q3 2025.
  • Funds reported $466M of Evommune Inc stock for Q4 2025.
  • 59 funds opened new Evommune Inc positions in Q4 2025 and 0 closed out, a net change of +59 holders.
  • The largest Evommune Inc buyer in Q4 2025 was EQT Fund Management, an estimated $92.6M added.

Based on aggregated 13F filings for Q4 2025.